M. Lalu

Statistics and Probability · 2012–2021

A researcher in the Science corpus: 5 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom M. Lalu trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Julian P. T. Higgins
  2. S. Green
  3. O. Ringdén
  4. A. Caplan

Papers from M. Lalu's perspective

Ordered by how strongly the researchers M. Lalu trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH) (Bone Marrow Transplantation)
  2. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. (Experimental Hematology)
  3. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. (The Lancet)
  4. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. (Biology of Blood and Marrow Transplantation)
  5. Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement and extensions: a scoping review (Systematic Reviews)
  6. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation (Annals of Internal Medicine)
  7. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews (British medical journal)
  8. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline (British medical journal)
  9. PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews (Journal of the Medical Library Association)
  10. Meta-analysis and the science of research synthesis (Nature)

Their papers